ICON to open new hub in Ireland; Divis Laboratories to build third manufacturing facility in India;

> Icon, an Ireland-based clinical research company, said it will open a new global innovation hub in the country that will create 200 new jobs. Announcement

> Indian API maker Divis Laboratories reported to the Bombay Stock Exchange that it intends to build a third manufacturing facility in India. Story

> Walgreens Infusion Services in Houston is recalling three dozen infusion products for lack of sterility assurance. Report

> CDMO Vetter has completed a €26 million ($29.7 million) expansion of its site in Ravensburg, Germany, that includes new labs and an IT upgrade. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.